Online Only Articles

Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis

Hematopathology Service
Department of Pathology
Hematopathology Service
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Hematopathology Service
Hematopathology Service
Vol. 103 No. 12 (2018): December, 2018 https://doi.org/10.3324/haematol.2018.203000